List of Figures
Figure 1: Dermatology Therapeutics Market, US, Innovation Trends in Product Approvals, Number of Product Approvals by FDA and Five-Year Moving Average of Product Approvals, 1987–2014 8
Figure 2: Dermatology Therapeutics Market, Sales Performance of First-in-Class and Non-First-in-Class Products Post Marketing Approval ($m), 2006–2013 9
Figure 3: Dermatology Therapeutics Market, Global, Marketed Products by Molecule Type, 2017 20
Figure 4: Dermatology Therapeutics Market, Global, Marketed Products by Molecular Target, 2017 21
Figure 5: Dermatology Therapeutics Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2017 22
Figure 6: Dermatology Therapeutics Market, Global, Pipeline by Stage of Development and Molecule Type, 2017 23
Figure 7: Dermatology Therapeutics Market, Global, Pipeline by Molecular Target and Stage of Development, 2017 25
Figure 8: Dermatology Therapeutics Market, Global, Distribution of Pipeline First-in-Class and Non-First-in-Class Products by Stage of Development and Molecular Target, 2017 26
Figure 9: Dermatology Therapeutics Market, Global, Percentage Distribution of First-in-Class and Non-First-in-Class Pipeline Products by Stage of Development (%), 2017 27
Figure 10: Dermatology Therapeutics Market, Global, Percentage Distribution of First-in-Class and Non-First-in-Class Pipeline Products by Molecular Target (%), 2017 27
Figure 11: Dermatology Therapeutics Market, Global, Ratio of First-in-Class Products to First-in-Class Targets by Stage of Development, 2017 27
Figure 12: Dermatology Therapeutics Market, Global, Ratio of First-in-Class Products to First-in-Class Targets by Molecular Target, 2017 28
Figure 13: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 1) 28
Figure 14: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 2) 29
Figure 15: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 3) 30
Figure 16: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 4) 31
Figure 17: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 5) 32
Figure 18: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 6) 33
Figure 19: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 7) 33
Figure 20: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 8) 34
Figure 21: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 9) 35
Figure 22: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 10) 36
Figure 23: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 11) 37
Figure 24: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 12) 38
Figure 25: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 13) 39
Figure 26: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 14) 40
Figure 27: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 15) 41
Figure 28: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 1) 43
Figure 29: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 2) 44
Figure 30: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 3) 44
Figure 31: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 4) 45
Figure 32: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 5) 45
Figure 33: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Infectious Diseases), 2017 46
Figure 34: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Wounds/Scars), 2017 47
Figure 35: Dermatology Therapeutics Market, Global, Industry-Wide Deals by Stage of Development and First-in-Class Status, 2006–2014 74
Figure 36: Dermatology Therapeutics Market, Global, Industry-Wide Licensing Deals by Deal Value, Upfront Payment Value, Stage of Development and First-in-Class Status, 2006–2014 75
Figure 37: Dermatology Therapeutics Market, Global, Licensing Deals by Region, Value and Year, 2006–2017 76
Figure 38: Dermatology Therapeutics Market, Global, Licensing Deals by Deal Value, Upfront Payment Value and Stage of Development, 2006–2017 77
Figure 39: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Licensing Deals by Molecule Type, 2006–2017 77
Figure 40: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Licensing Deals by Molecular Target, 2006–2017 78
Figure 41: Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006–2017 (Part 1) 79
Figure 42: Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006–2017 (Part 2) 80
Figure 43: Dermatology Therapeutics Market, Global, Co-development Deals by Region, Value and Year, 2006–2017 81
Figure 44: Dermatology Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2017 82
Figure 45: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Co-development Deals by Molecule Type, 2006–2017 82
Figure 46: Dermatology Therapeutics Market, Global, Number of Co-development Deals by Molecular Target, 2006–2017 83
Figure 47: Dermatology Therapeutics Market, Global, Co-development Deals with Disclosed Deal Values, 2006–2017 84
Figure 48: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with Prior Involvement in Licensing or Co-development Deals, 2017 85
Figure 49: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 1), 2017 86
Figure 50: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 2), 2017 87
Figure 51: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 3), 2017 88
Figure 52: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 4), 2017 89